Justiz-Vaillant Angel, Gopaul Darren, Soodeen Sachin, Unakal Chandrashekhar, Thompson Reinand, Pooransingh Shalini, Arozarena-Fundora Rodolfo, Asin-Milan Odalis, Akpaka Patrick Eberechi
Department of Para-Clinical Sciences, University of the West Indies, St. Augustine Campus, St. Augustine 00000, Trinidad and Tobago.
Port of Spain General Hospital, University of the West Indies, St. Augustine Campus, St. Augustine 00000, Trinidad and Tobago.
Microorganisms. 2024 Aug 14;12(8):1672. doi: 10.3390/microorganisms12081672.
Immunology and microbiology research has witnessed remarkable growth and innovation globally, playing a pivotal role in advancing our understanding of immune mechanisms, disease pathogenesis, and therapeutic interventions. This manuscript presents a comprehensive exploration of the key areas in immunology research, spanning from the utilisation of bacterial proteins as antibody reagents to the intricate realms of clinical immunology and disease management. The utilisation of bacterial immunoglobulin-binding proteins (IBPs), including protein A (SpA), protein G (SpG), and protein L (SpL), has revolutionised serological diagnostics, showing promise in early disease detection and precision medicine. Microbiological studies have shed light on antimicrobial resistance patterns, particularly the emergence of extended-spectrum beta-lactamases (ESBLs), guiding antimicrobial stewardship programmes and informing therapeutic strategies. Clinical immunology research has elucidated the molecular pathways underlying immune-mediated disorders, resulting in tailored management strategies for conditions such as severe combined immunodeficiency (SCID), neuropsychiatric systemic lupus erythematosus (NPSLE), etc. Additionally, significant efforts in vaccine development against tuberculosis and HIV are highlighted, underscoring the ongoing global pursuit of effective preventive measures against these infectious diseases. In summary, immunology and microbiology research have provided significant contributions to global healthcare, fostering collaboration, innovation, and improved patient outcomes.
免疫学和微生物学研究在全球范围内取得了显著的发展和创新，在推动我们对免疫机制、疾病发病机制及治疗干预的理解方面发挥着关键作用。本手稿全面探讨了免疫学研究的关键领域，涵盖从利用细菌蛋白作为抗体试剂到临床免疫学和疾病管理的复杂领域。细菌免疫球蛋白结合蛋白（IBP）的利用，包括蛋白A（SpA）、蛋白G（SpG）和蛋白L（SpL），彻底改变了血清学诊断，在疾病早期检测和精准医学方面展现出前景。微生物学研究揭示了抗菌药物耐药模式，尤其是超广谱β-内酰胺酶（ESBL）的出现，为抗菌药物管理计划提供了指导并为治疗策略提供了依据。临床免疫学研究阐明了免疫介导疾病的分子途径，从而为严重联合免疫缺陷（SCID）、神经精神性系统性红斑狼疮（NPSLE）等疾病制定了量身定制的管理策略。此外，还强调了在结核病和艾滋病疫苗研发方面所做的重大努力，突显了全球对这些传染病有效预防措施的持续追求。总之，免疫学和微生物学研究为全球医疗保健做出了重大贡献，促进了合作、创新并改善了患者预后。
